Vivek P Chavda,Pankti C Balar,Srushti B Patel
Vivek P Chavda
Interventional nanotheranostics is a system of drug delivery that does a dual function; along with the therapeutic action, it also does have diagnostic features. This method helps in early detection, targeted delivery, and the least chances...
Longitudinal NMR Based Serum Metabolomics to Track the Potential Serum Biomarkers of Septic Shock [0.03%]
纵向核磁共振基于血清代谢组学追踪脓毒性休克潜在血清生物标志物
Swarnima Pandey,Afzal Azim,Neeraj Sinha
Swarnima Pandey
Background: Septic shock, with a prolonged hospital stay, has the highest mortality rate worldwide. There is a need for better management of the disease, which requires time-dependent analysis of alteration occurring in the disease conditio...
Vivek P Chavda,Pankti C Balar,Srushti B Patel
Vivek P Chavda
Head and neck cancer is affecting a large sort of population. Many treatments are available on a regular base, but they have their limitations. Diagnosis in the early stage is essential to cope with the disease which is a limitation in the ...
Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer [0.03%]
药物递送：癌细胞治疗平台的脂质-聚合物纳米杂化体研究
Rahul Kumar,Vinish Ranjan Srivastava,Supratim Mahapatra et al.
Rahul Kumar et al.
The focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer syst...
High-resolution synchrotron K-edge subtraction CT allows tracking and quantifying therapeutic cells and their scaffold in a rat model of focal cerebral injury and can serve as a reference for spectral photon counting CT [0.03%]
基于大鼠局灶性脑损伤模型的高分辨率同步K边减影CT可以追踪和量化治疗细胞及其支架并可作为光子计数CT参考
Clément Tavakoli,Elisa Cuccione,Chloé Dumot et al.
Clément Tavakoli et al.
Background: The objective of this study was to demonstrate that synchrotron K-edge subtraction tomography (SKES-CT) can simultaneously track therapeutic cells and their encapsulating carrier, in vivo, in a rat model of focal brain injury us...
Personalized biosensors for point-of-care diagnostics: from bench to bedside applications [0.03%]
从实验室到临床应用的个性化生物传感器点-of-护理诊断
Pranjal Chandra
Pranjal Chandra
The most significant feature of translational point-of-care technology "Personalized biosensors" is that it can be done quickly and by clinical staff who are not trained in clinical laboratory sciences. Rapid test results can quickly give a...
A Perspective on Using Organic Molecules Composing Carbon Dots for Cancer Treatment [0.03%]
用于癌症治疗的组成型碳点有机分子的观点
Musbahu Adam Ahmad,Yu-Yu Aung,Alfa Akustia Widati et al.
Musbahu Adam Ahmad et al.
Fluorescent Carbon dots (CDs) derived from biologically active sources have shown enhanced activities compared to their precursors. With their prominent potentiality, these small-sized (
Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer [0.03%]
金纳米颗粒偶联树状支链聚赖氨酸和叶酸靶向PEG用于前列腺癌siRNA递送
Georges Minassian,Esther Ghanem,Roland El Hage et al.
Georges Minassian et al.
Dendrigraft Poly-L-Lysine (d-PLL) coated gold nanoparticles (AuNPs) were synthesized by reducing Tetrachloroauric acid with ascorbic acid in the presence of d-PLL. AuNPs-d-PLL formed a stable colloidal solution that absorbs light at a maxim...
Development of a Personalised Device for Systemic Magnetic Drug Targeting to Brain Tumours [0.03%]
个性化装置的发展用于脑肿瘤的系统性磁药靶向治疗
Priya Patel,Areej Alghamdi,Gary Shaw et al.
Priya Patel et al.
Delivering therapies to deeply seated brain tumours (BT) is a major clinical challenge. Magnetic drug targeting (MDT) could overcome this by rapidly transporting magnetised drugs directly into BT. We have developed a magnetic device for app...
A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery [0.03%]
介孔纳米颗粒作为经皮给药载体的发展系统评价.Xr: ['介孔纳米颗粒作为经皮给药载体的发展系统评价。'] 最终答案：介孔纳米颗粒作为经皮给药载体的发展系统评价。
Praveen Kolimi,Sagar Narala,Ahmed Adel Ali Youssef et al.
Praveen Kolimi et al.
Recent advances in drug delivery technologies utilizing a variety of carriers have resulted in a paradigm shift in the current approach to diagnosis and therapy. Mesoporous silica nanoparticles (MSNs) were developed in response to the need ...